Aptose Biosciences Inc. (APTO)
NASDAQ: APTO · Real-Time Price · USD
0.278
+0.005 (1.72%)
Nov 21, 2024, 12:02 PM EST - Market open
Aptose Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -35.8 | -51.21 | -41.82 | -65.35 | -55.24 | -26.28 | |
Depreciation & Amortization | 0.42 | 0.47 | 0.53 | 0.62 | 0.61 | 0.61 | |
Loss (Gain) From Sale of Assets | 0.08 | - | 0.02 | - | - | - | |
Stock-Based Compensation | 1.41 | 3.65 | 5.21 | 12.95 | 21.44 | 2.3 | |
Other Operating Activities | 0.13 | 0.09 | -0.02 | 7.52 | 0.09 | 0.39 | |
Change in Accounts Payable | -0.98 | -0.28 | 7.61 | -0.47 | 0.21 | 0.65 | |
Change in Other Net Operating Assets | -2.43 | 2.69 | -3.84 | 1.43 | -1.01 | 0.77 | |
Operating Cash Flow | -37.18 | -44.59 | -32.32 | -43.3 | -33.89 | -21.56 | |
Capital Expenditures | - | -0.03 | -0.02 | -0.21 | -0.08 | -0.1 | |
Investment in Securities | 1.94 | 9.99 | 30.09 | -35 | 12.71 | -17.27 | |
Investing Cash Flow | 1.96 | 9.96 | 30.07 | -35.21 | 12.63 | -17.37 | |
Issuance of Common Stock | 27.63 | 6.91 | 0.12 | 0.23 | 58.98 | 103.89 | |
Other Financing Activities | -0.17 | - | - | - | -0.17 | -0.44 | |
Financing Cash Flow | 27.46 | 6.91 | 0.12 | 0.23 | 58.81 | 103.45 | |
Foreign Exchange Rate Adjustments | -0 | 0 | -0 | 0.01 | 0.01 | 0.02 | |
Net Cash Flow | -7.76 | -27.72 | -2.14 | -78.28 | 37.55 | 64.54 | |
Free Cash Flow | -37.18 | -44.62 | -32.35 | -43.52 | -33.97 | -21.66 | |
Free Cash Flow Per Share | -2.65 | -6.61 | -5.26 | -7.33 | -6.23 | -6.48 | |
Levered Free Cash Flow | -23.76 | -25.82 | -16.6 | -26.03 | -13.14 | -12.17 | |
Unlevered Free Cash Flow | -23.76 | -25.82 | -16.6 | -26.03 | -13.14 | -12.17 | |
Change in Net Working Capital | 2.97 | -2.81 | -4.32 | -1.52 | 0.26 | -1.81 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.